Teleflex(NYSE) TFX

Current Price$131.95

Market Cap$5.85B

Since IPO (1968)+91,152%

5 Year-66%

1 Year+15%

1 Month+4%

Teleflex last closing stock price
Metric	Price	Date
Last close	USD 132.10	2026-07-24

Teleflex stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-1.86%	USD 134.61	2026-07-17
1 month	+4.42%	USD 126.51	2026-06-24
3 month	-3.02%	USD 136.21	2026-04-24
Year to date	+8.84%	USD 121.37	2025-12-31
1 year	+14.99%	USD 114.88	2025-07-24
3 year	-47.05%	USD 249.49	2023-07-25
5 year	-65.58%	USD 383.83	2021-07-23
Since inception	+91,152.19%	USD 0.14	1968-01-02

Teleflex Financials at a Glance

Market Cap

$5.85B

Revenue (TTM)

$2.81B

Net Income (TTM)

-$1.01B

EPS (TTM)

-$22.81

P/E Ratio

-5.79

Dividend

$1.36

Beta (Volatility)

0.85 (Low)

Dividend

$1.36

Beta (Volatility)

0.85 (Low)

Price

$131.95

Volume

514,544

Open

$131.24

Price

$131.95

Volume

514,544

Open

$131.24

Previous Close

$132.10

Daily Range

$130.70 - $133.94

52-Week Range

$100.18 - $139.67

Estimated Earnings Date

Jul 30, 2026

Dividend

$1.36

Beta (Volatility)

0.85 (Low)

Price

$131.95

Volume

514,544

Open

$131.24

Previous Close

$132.10

Daily Range

$130.70 - $133.94

52-Week Range

$100.18 - $139.67

Estimated Earnings Date

Jul 30, 2026

TFX News

Teleflex Stock Slides 39% in a Year, but This $8.5 Million Buy Signals a Contrarian Bet

Jonathan PoncianoFeb 6, 2026

Teleflex Beats Analyst Estimates on EPS

Seth JaysonJul 31, 2013

Has Teleflex Made You Any Real Money?

Seth JaysonJul 10, 2013

What Teleflex's Earnings Headlines Didn't Tell You

Seth JaysonJun 6, 2013

Some Numbers at Teleflex that Make Your Stock Look Good

Seth JaysonMay 22, 2013

Page 1

TFX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Teleflex

Teleflex helps doctors and nurses treat sick patients safely and easily. It makes single-use tools for surgeries and critical heart or lung care. These products help lower the risk of infections during medical procedures.

The Tool Kit

Vascular: Catheters and bone-access systems used to give fluids or take blood samples; often include coatings to prevent infections.
Interventional: Specialized tubes and heart support devices used by cardiologists to treat vein and artery diseases.
Surgical: Clips and staplers used to close wounds or body tissues during operating room procedures.

Transforming the Business

Acquired the Vascular Intervention business of BIOTRONIK SE & Co. KG on June 30, 2025, adding stents and balloon catheters to the portfolio.
Entered definitive agreements on December 9, 2025, to sell the Acute Care and Interventional Urology businesses to Intersurgical Ltd for $530 million.
Agreed to sell the OEM business to Montagu and Kohlberg on December 9, 2025, for approximately $1.5 billion.
Completed the final phase of a respiratory business divestiture to Medline Industries in December 2023 with the transfer of manufacturing assets.

Global Reach and Operations

The company operates major manufacturing sites in the Czech Republic, Malaysia, Mexico, and the United States. Its massive workforce of 15,500 employees supports healthcare providers across approximately 40 countries through a mix of direct sales and distributors.

Financial Performance

Revenue reached $569 million in Q4 2025, down 28.5% from $795.4 million in Q4 2024.
Operating income rose to $36.3 million in Q4 2025, up 132.9% from a loss of $110.4 million in Q4 2024.
Free cash flow was $151.6 million in Q4 2025, down 11.1% from $170.4 million in Q4 2024.
Net income fell to a loss of $714.3 million in Q4 2025, down 422.7% from a loss of $136.7 million in Q4 2024.

Bottom Line

Teleflex is shifting from a broad medical manufacturer to a focused provider of high-acuity surgical and vascular tools. This transition includes the planned sale of its urology and anesthesia segments to simplify operations and improve long-term costs.

AI Generated • Apr 23, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

15,500

CEO

Stuart Allen Randle, MBA

Website

www.teleflex.com

Headquarters

Wayne, PA 19087-1603, US

TFX Financials

Key Financial Metrics (TTM)

Gross Margin

53.27%

Operating Margin

6.48%

Net Income Margin

-35.89%

Return on Equity

-28.27%

Return on Capital

4.37%

Return on Assets

-14.87%

Earnings Yield

-17.27%

Dividend Yield

1.03%

Payout Ratio

-5.96%

Stock Overview

Market Cap

$5.85B

Shares Outstanding

44.27M

Volume

514.54K

Avg. Volume

593.97K

Financials (TTM)

Gross Profit

$1.50B

Operating Income

$182.14M

EBITDA

-$88.47M

Operating Cash Flow

$314.25M

Capital Expenditure

-$65.23M

Free Cash Flow

$249.02M

Cash & ST Invst.

$309.41M

Total Debt

$2.69B

Teleflex Performance Analysis

Teleflex annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	USD 2,791,041,000	-0.7%
2023	2023-12-31	USD 2,974,489,000	6.6%
2024	2024-12-31	USD 1,699,546,000	-42.9%
2025	2025-12-31	USD 1,992,713,000	17.2%

Teleflex sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-06-29	11.4%
Q3	2025-09-28	16.9%
Q4	2025-12-31	-37.7%
Q1	2026-03-31	-3.6%

Teleflex annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	USD 7.68	-25.0%
2023	2023-12-31	USD 7.53	-1.9%
2024	2024-12-31	USD 1.48	-80.4%
2025	2025-12-31	USD -20.30	N/A

Teleflex sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-06-29	33.8%
Q3	2025-09-28	-433.6%
Q4	2025-12-31	-74.8%
Q1	2026-03-31	98.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$548.26M

-21.8%

Gross Profit

$307.43M

-21.1%

Gross Margin

56.07%

N/A

Market Cap

$5.85B

N/A

Market Cap/Employee

$377.30K

N/A

Employees

15,500

N/A

Net Income

-$8.15M

-108.6%

EBITDA

-$3.83M

-102.0%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$309.41M

+8.9%

Total Debt

$2.69B

+34.0%

Accounts Receivable

$365.53M

-21.3%

Inventory

$380.86M

-40.9%

Long Term Debt

$2.58B

+35.6%

Short Term Debt

$103.13M

+3.1%

Return on Assets

-14.87%

N/A

Return on Invested Capital

3.01%

N/A

Free Cash Flow

$46.66M

+8.3%

Operating Cash Flow

$46.66M

-36.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

BLCOBausch + Lomb Corporation

BLCOBausch + Lomb Corporation$16.17+1.19%

STVNStevanato Group S.p.A.

STVNStevanato Group S.p.A.$19.68+1.44%

PTCTPTC Therapeutics, Inc.

PTCTPTC Therapeutics, Inc.$76.82-2.08%

CRSPCRISPR Therapeutics AG

CRSPCRISPR Therapeutics AG$46.54-2.08%

MMSIMerit Medical Systems, Inc.

MMSIMerit Medical Systems, Inc.$74.32+1.66%

PCVXVaxcyte, Inc.

PCVXVaxcyte, Inc.$54.66-1.76%

TGTXTG Therapeutics, Inc.

TGTXTG Therapeutics, Inc.$56.04+0.97%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$9.10-0.06%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$7.42-0.04%

ONDSOndas

ONDSOndas$7.80-0.02%

CLFCleveland-Cliffs

CLFCleveland-Cliffs$11.93+0.09%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$64.00-0.03%

STAKStak

STAKStak$9.27+6.02%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$115.07-0.03%

Questions About TFX

What is the current price of Teleflex?

Teleflex is trading at $132.10 per share.

What is the 52-week range for Teleflex?

Over the past 52 weeks, Teleflex has traded between $100.18 and $139.67.

How much debt does Teleflex have?

As of the most recent reporting period, Teleflex reported total debt of $2.69B.

How much cash does Teleflex have on hand?

Teleflex reported $324.11M in cash and cash equivalents in its most recent financial results.

What is Teleflex’s dividend yield?

Teleflex currently has a dividend yield of 1.03%.

Teleflex(NYSE) TFX

Teleflex Financials at a Glance

TFX News

Teleflex Stock Slides 39% in a Year, but This $8.5 Million Buy Signals a Contrarian Bet

Why One Fund Just Bet $4 Million on Teleflex Stock Despite a 42% One-Year Drop

Teleflex Announces Split Into 2 Public Companies

PG&E Gets Booted From the S&P 500. Meet Its Replacement

Teleflex Beats Analyst Estimates on EPS

Has Teleflex Made You Any Real Money?

What Teleflex's Earnings Headlines Didn't Tell You

Some Numbers at Teleflex that Make Your Stock Look Good

TFX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Teleflex

The Tool Kit

Transforming the Business

Global Reach and Operations

Financial Performance

Bottom Line

TFX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Teleflex Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About TFX

What is the current price of Teleflex?

What is the 52-week range for Teleflex?

How much debt does Teleflex have?

How much cash does Teleflex have on hand?

What is Teleflex’s dividend yield?

Premium Investing Services